BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 15836656)

  • 1. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis.
    Burger W; Chemnitius JM; Kneissl GD; Rücker G
    J Intern Med; 2005 May; 257(5):399-414. PubMed ID: 15836656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin withdrawal prior to invasive medical procedures: a strategy based on thromboembolic and bleeding risk stratification.
    Szalat A; Erez G; Leitersdorf E
    Isr Med Assoc J; 2007 Jun; 9(6):435-8. PubMed ID: 17642389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?
    Laine L
    Aliment Pharmacol Ther; 2006 Sep; 24(6):897-908. PubMed ID: 16948802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.
    Berger JS; Brown DL; Becker RC
    Am J Med; 2008 Jan; 121(1):43-9. PubMed ID: 18187072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin and bleeding in dentistry: an update and recommendations.
    Brennan MT; Wynn RL; Miller CS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Sep; 104(3):316-23. PubMed ID: 17618144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose aspirin for primary prevention of cardiovascular disease.
    Bredie SJ; Wollersheim H; Verheugt FW; Thien T
    Semin Vasc Med; 2003 May; 3(2):177-84. PubMed ID: 15199480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome.
    Gerstein NS; Schulman PM; Gerstein WH; Petersen TR; Tawil I
    Ann Surg; 2012 May; 255(5):811-9. PubMed ID: 22470078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Withdrawing the use of acetylsalicyclic acid prior to an operation usually not necessary].
    Fijnheer R; Urbanus RT; Nieuwenhuis HK
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):21-5. PubMed ID: 12564293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs.
    Taylor K; Filgate R; Guo DY; Macneil F
    BJU Int; 2011 Nov; 108 Suppl 2():45-50. PubMed ID: 22085127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin in cardiology--benefits and risks.
    Björklund L; Wallander MA; Johansson S; Lesén E
    Int J Clin Pract; 2009 Mar; 63(3):468-77. PubMed ID: 19222632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative cardiovascular evaluation for noncardiac surgery.
    Maddox TM
    Mt Sinai J Med; 2005 May; 72(3):185-92. PubMed ID: 15915313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin to prevent heart attack and stroke: what's the right dose?
    Dalen JE
    Am J Med; 2006 Mar; 119(3):198-202. PubMed ID: 16490462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
    Ehrlich Y; Yossepowitch O; Margel D; Lask D; Livne PM; Baniel J
    J Urol; 2007 Aug; 178(2):524-8; discussion 528. PubMed ID: 17570430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis.
    Younis N; Williams S; Ammori B; Soran H
    Expert Opin Pharmacother; 2010 Jun; 11(9):1459-66. PubMed ID: 20429671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME; Greenberg BP
    Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.
    Hennekens CH; Sechenova O; Hollar D; Serebruany VL
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):170-6. PubMed ID: 17056829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.